KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Current Deferred Revenue (2018 - 2023)

Tenet Healthcare's Current Deferred Revenue history spans 6 years, with the latest figure at $86.0 million for Q3 2023.

  • For Q3 2023, Current Deferred Revenue fell 22.52% year-over-year to $86.0 million; the TTM value through Sep 2023 reached $86.0 million, down 22.52%, while the annual FY2022 figure was $110.0 million, 87.44% down from the prior year.
  • Current Deferred Revenue for Q3 2023 was $86.0 million at Tenet Healthcare, up from $76.0 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $1.5 billion in Q3 2020 and bottomed at $60.0 million in Q1 2021.
  • The 5-year median for Current Deferred Revenue is $110.0 million (2022), against an average of $462.8 million.
  • The largest annual shift saw Current Deferred Revenue surged 2132.84% in 2020 before it crashed 90.89% in 2022.
  • A 5-year view of Current Deferred Revenue shows it stood at $72.0 million in 2019, then surged by 608.33% to $510.0 million in 2020, then soared by 71.76% to $876.0 million in 2021, then plummeted by 87.44% to $110.0 million in 2022, then dropped by 21.82% to $86.0 million in 2023.
  • Per Business Quant, the three most recent readings for THC's Current Deferred Revenue are $86.0 million (Q3 2023), $76.0 million (Q2 2023), and $76.0 million (Q1 2023).